Arch Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q2 2012 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Arch Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q2 2012 to Q3 2023.
  • Arch Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending September 30, 2023 was $17.6M, a 12.6% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $17.6M +$1.98M +12.6% Sep 30, 2023 10-K 2024-02-15
Q3 2022 $15.6M +$483K +3.19% Sep 30, 2022 10-K 2024-02-15
Q3 2021 $15.1M +$1.63M +12% Sep 30, 2021 10-K 2022-12-28
Q3 2020 $13.5M +$1.46M +12.1% Sep 30, 2020 10-K 2021-12-17
Q3 2019 $12.1M +$1.84M +17.9% Sep 30, 2019 10-K 2020-12-11
Q3 2018 $10.2M -$1.44M -12.3% Sep 30, 2018 10-K 2019-11-19
Q3 2017 $11.7M +$3.04M +35.3% Sep 30, 2017 10-K 2018-12-18
Q3 2016 $8.62M +$2.77M +47.3% Sep 30, 2016 10-K 2017-11-15
Q3 2015 $5.86M +$2.13M +57.2% Sep 30, 2015 10-K 2016-12-05
Q3 2014 $3.73M +$2.2M +144% Sep 30, 2014 10-K 2015-12-11
Q3 2013 $1.52M +$589K +63% Sep 30, 2013 10-K 2014-12-12
Q4 2012 -$14.6K* Dec 31, 2012 10-Q 2013-02-14
Q3 2012 $935K Sep 30, 2012 10-K/A 2014-05-01
Q2 2012 -$7.1K* Jun 30, 2012 10-Q 2012-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.